GlaxoSmithKline reported 2.82B in Cost of Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4341M 157M
Alcon AG ALC:SW 908M 18M
Amgen AMGN:US $ 1609M 28M
AstraZeneca AZN:LN 3824M 1631M
Bayer BAYN:GR € 3887M 659M
Biogen BIIB:US $ 511.8M 52.1M
Bristol Myers Squibb BMY:US $ 2291M 160M
Eli Lilly And LLY:US $ 1430.8M 522.4M
Fresenius FRE:GR € 6801M 173M
Fresenius Medical Care FME:GR € 3174M 137.82M
Gilead Sciences GILD:US $ 1223M 167M
GlaxoSmithKline GSK:LN 2822M 303M
Glaxosmithkline GSK:US $ 2822M 303M
GRIFOLS GRF:SM € 771.1M 119.7M
H. Lundbeck A/S LUN:DC 851M 0
Hikma Pharmaceutical HIK:LN 600M 2M
Lonza Group LONN:SW 1.5B 690M
Merck MRK:GR € 1859M 46M
Merk MRK:US $ 3056M 14M
Novartis NOVN:VX SF 3848M 94M
Orion ORNBV:FH 110.3M 10.7M
Pfizer PFE:US $ 9931M 2939M
Philips PHIA:NA € 2182M 259M
Recordati REC:IM 107.06M 5.19M
Regeneron Pharmaceuticals REGN:US $ 453.2M 240.5M